Table 1.
Significantly Enriched Proteins Identified by Combined Mascot and SEQUEST Database Searches and Combined Spectral Counting and MS2 TIC Features Generated in Scaffold 4 Software Comparing Deyolked and Nondeyolked Control Zebrafish Embryos
| Protein name | Accession number | Molecular weight (kDa) | Student's t-test or G-testa(p < 0.05) | Yolk average: total MS2 TIC or spectral countsb | Deyolked average: total MS2 TIC or spectral countsb |
|---|---|---|---|---|---|
| Aconitase 2, mitochondrialc | F8W4M7_DANRE | 86 | 0.002 | Not identified without deyolking | 1.70E+04 ± 2.34E+03 |
| Actin, alpha 1, skeletal muscled | Q9I8V1_DANRE | 42 | 0.008 | 1.92E+06 ± 2.52E+05 | 4.20E+06 ± 3.86E+05 |
| Actinodin 2c | A9JRX1_DANRE | 57 | 0.037 | Not identified without deyolking | 1.59E+04 ± 5.16E+03 |
| Adenosine monophosphate deaminase 1 (Isoform M)c,e | Q6P3G5_DANRE | 83 | 0.045 | Not identified without deyolking | 5.43E+04 ± 1.88E+04 |
| Adenylate kinase isoenzyme 1c,e | Q68EH2_DANRE | 21 | 0.030 | 4.69E+04 ± 1.48E+04 | 1.02E+05 ± 8.06E+03 |
| ATP synthase subunit alphad | Q08BA1_DANRE | 60 | <0.001 | 8.32E+04 ± 4.65E+03 | 3.71E+05 ± 1.02E+04 |
| ATP synthase subunit betad | F1R2V7_DANRE | 56 | 0.001 | Not identified without deyolking | 3.75E+05 ± 4.71E+04 |
| ATPase, H+ transporting, lysosomal, V1 subunit Abc,e | E7FCD8_DANRE | 68 | 0.005 | Not identified without deyolking | 2.94E+05 ± 5.26E+04 |
| BetaA2-2-crystallinc,e | Q45FX9_DANRE | 24 | 0.015 | Not identified without deyolking | 4.97E+03 ± 1.21E+03 |
| Brain-subtype creatine kinasec,e | Q8AY63_DANRE | 43 | 0.012 | Not identified without deyolking | 1.82E+05 ± 4.15E+04 |
| Calsequestrinc,e | F1QNI9_DANRE | 32 | 0.018 | Not identified without deyolking | 8.68E+04 ± 2.24E+04 |
| F1QXT6_DANRE | |||||
| Clathrin heavy chainc,e | F1R966_DANRE | 192 | 0.012 | Not identified without deyolking | 4.91E+04 ± 1.12E+04 |
| Creatine kinase, mitochondrial 2 (Sarcomeric)c,e | Q6PC86_DANRE | 46 | 0.036 | Not identified without deyolking | 2.02E+04 ± 6.49E+03 |
| Creatine kinase, muscle ad | A2BHA3_DANRE | 43 | 0.007 | Not identified without deyolking | 6.30E+05 ± 1.22E+05 |
| Creatine kinase, muscle bd | Q7T306_DANRE | 43 | 0.004 | Not identified without deyolking | 2.53E+05 ± 4.26E+04 |
| Crystallin, beta B1c | F1QT01_DANRE | 29 | 0.041 | Not identified without deyolking | 5.63E+04 ± 1.89E+04 |
| Dachsous cadherin-related 1ac,e | F1R256_DANRE | 352 | 0.004 | 2.26E+04 ± 2.26E+04 | 1.64E+05 ± 5.81E+03 |
| X1WDW2_DANRE | |||||
| Elongation factor 1-gammac | EF1G_DANRE | 50 | 0.001 | Not identified without deyolking | 5.85E+04 ± 7.10E+03 |
| Epiphycanc | B0S5X0_DANRE | 75 | <0.001 | Not identified without deyolking | 8.00E+04 ± 4.24E+03 |
| Q5RI46_DANRE | |||||
| Fast skeletal muscle myosin light polypeptide 3c | Q9I8U7_DANRE | 17 | 0.014 | 7.23E+05 ± 1.19E+05 | 1.48E+06 ± 1.34E+05 |
| Fructose-bisphosphate aldolasec | Q803Q7_DANRE | 40 | 0.025 | Not identified without deyolking | 5.98E+03 ± 1.70E+03 |
| GDP dissociation inhibitor 2c,e | Q6TNT9_DANRE | 51 | 0.007 | Not identified without deyolking | 6.23E+04 ± 1.23E+04 |
| Glyceraldehyde-3-phosphate dehydrogenased | F1R3D3_DANRE | 36 | 0.001 | Not identified without deyolking | 4.31E+05 ± 4.81E+04 |
| G3P2_DANRE | |||||
| G-protein-coupled receptor 98c,e | F1QEZ1_DANRE | 674 | 0.019 | 3.56E+03 ± 3.56E+03 | 2.50E+04 ± 4.30E+03 |
| Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1c,e | GBB1_DANRE | 37 | 0.034 | Not identified without deyolking | 1.32E+05 ± 4.16E+04 |
| Heat shock 60kD protein 1 (Chaperonin)c | Q803B0_DANRE | 61 | 0.046 | Not identified without deyolking | 1.90E+04 ± 6.61E+03 |
| Heterochromatin protein 1, binding protein 3c | E7FAZ5_DANRE | 65 | 0.017 | Not identified without deyolking | 6.55E+04 ± 1.65E+04 |
| Heterogeneous nuclear ribonucleoprotein A0, likec,e | Q7ZU48_DANRE | 32a | 0.006 | Not identified without deyolking | 8.92E+04 ± 1.70E+04 |
| Heterogeneous nuclear ribonucleoprotein Lc,e | Q7ZW09_DANRE | 59 | 0.017 | Not identified without deyolking | 9.16E+04 ± 2.31E+04 |
| Histone H3.2c | H32_DANRE | 15 | 0.010 | 6.46E+04 ± 3.93E+04 | 2.49E+05 ± 9.72E+03 |
| X1WC76_DANRE | |||||
| Hydroxysteroid (17-beta) dehydrogenase 10c | Q5XJS8_DANRE | 27 | 0.017 | Not identified without deyolking | 4.23E+04 ± 1.07E+04 |
| Malate dehydrogenased | Q7T334_DANRE | 35 | <0.001 | 3.66E+04 ± 2.70E+04 | 5.85E+05 ± 8.91E+03 |
| Malic enzymec,e | A4QPA0_DANRE | 67 | 0.009 | Not identified without deyolking | 1.81E+04 ± 3.83E+03 |
| Myosin light chain, phosphorylatable, fast skeletal muscle ac | O93409_DANRE | 19 | 0.006 | 2.08E+05 ± 2.71E+04 | 4.76E+05 ± 4.29E+04 |
| Myosin, heavy polypeptide 1.2, skeletal musclef | B8A561_DANRE | 222 | <0.001 | Not identified without deyolking | 8.45E+01 ± 4.18E+01f |
| NADH dehydrogenase (ubiquinone) alpha subcomplex, 5c,e | Q5BJA2_DANRE | 13 | 0.003 | Not identified without deyolking | 4.92E+04 ± 7.63E+03 |
| Nucleoside diphosphate kinasec,e | Q7SXL4_DANRE | 17 | 0.025 | 4.41E+04 ± 1.57E+04 | 1.59E+05 ± 2.92E+04 |
| Periostin, osteoblast specific factor bc,e | E7FBL9_DANRE | 86 | 0.030 | 1.01E+04 ± 1.01E+04 | 5.16E+04 ± 7.47E+03 |
| F1QHK3_DANRE | |||||
| Q75U66_DANRE | |||||
| Phosphorylasec,e | Q503C7_DANRE | 97 | 0.034 | 9.02E+03 ± 9.02E+03 | 1.64E+05 ± 4.79E+04 |
| Pyrophosphatase (inorganic) 1bc,e | B7ZD39_DANRE | 33 | 0.015 | Not identified without deyolking | 9.36E+04 ± 2.29E+04 |
| Pyruvate kinased | F1QEN1_DANRE | 67a | <0.001 | Not identified without deyolking | 2.74E+05 ± 8.59E+03 |
| F1QSE0_DANRE | |||||
| F1RBK3_DANRE | |||||
| Ribosomal protein S5c,e | Q6PC80_DANRE | 23 | 0.011 | Not identified without deyolking | 1.76E+05 ± 3.94E+04 |
| Synaptosomal-associated protein 91c,e | E7F4Z2_DANRE | 94 | 0.049 | Not identified without deyolking | 5.59E+04 ± 2.00E+04 |
| E9QBM8_DANRE | |||||
| Synaptotagmin binding, cytoplasmic RNA interacting proteinc | F1QY96_DANRE | 77 | 0.011 | 5.81E+04 ± 1.46E+04 | 2.31E+05 ± 3.56E+04 |
| Q6NUZ3_DANRE | |||||
| Titin Ad | F1R7N8_DANRE | 3487 | 0.009 | 1.86E+04 ± 1.86E+04 | 1.84E+05 ± 2.95E+04 |
| Titin Bd | F1Q6U3_DANRE | 3026 | 0.026 | 2.79E+04 ± 2.47E+03 | 1.60E+05 ± 3.83E+04 |
| Transforming growth factor, beta-inducedc,e | Q503K1_DANRE | 74 | 0.022 | Not identified without deyolking | 1.03E+05 ± 2.84E+04 |
| Tryosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptidec,e | Q803M8_DANRE | 28 | <0.001 | Not identified without deyolking | 1.72E+04 ± 1.35E+03 |
| Tubulin, alpha 1cf | B8A518_DANRE | 50 | 0.027 | 2.43E+00 ± 0.72E+00f | 9.96E+00 ± 0.24E+00f |
| Ubiquinol-cytochrome c reductase core protein Ic,e | F1QUE3_DANRE | 55 | 0.004 | Not identified without deyolking | 1.99E+04 ± 3.44E+03 |
| Uncharacterized ionotropic glutamate receptor family protein si:ch211-251b21.1c | B8JLR6_DANRE | 50 | <0.001 | Not identified without deyolking | 1.69E+05 ± 1.43E+04 |
| Uncharacterized actin family protein zgc:86725d | F1RCB6_DANRE | 42 | 0.001 | 1.60E+06 ± 7.82E+04 | 3.27E+06 ± 1.84E+05 |
Minimum protein identification confidence: 99%, minimum peptide identification confidence: 95% requiring at least 2 peptides per protein. G-test or Student's t-test was accepted at p < 0.05 with at least a 1.5-fold change.
Student's t-test for total MS2 TIC, unless significant enrichment was detected only with spectral counting for which the G-test is reported.
Spectral counts, if significant enrichment detected only with spectral counting—otherwise, total MS2 TIC. Total MS2 TIC and spectral counts are given as average ± standard error.
Significant enrichment detected only using MS2 TIC criteria.
Significant enrichment detected with both spectral counting and using MS2 TIC criteria.
Identification made by SEQUEST alone.
Significant enrichment detected only with spectral counting.
MS2 TIC, MS/MS total ion current.